Malone D C, Okano G J
Department of Pharmacy Practice, School of Pharmacy, University of Colorado Health Sciences Center, Denver 80262-0238, USA.
Clin Ther. 1999 May;21(5):867-77. doi: 10.1016/s0149-2918(99)80008-3.
Urinary incontinence has far-reaching medical, psychological, social, and economic effects. The objectives of this descriptive study were to examine utilization patterns and discontinuation rates of various pharmacologic agents used to treat symptoms of overactive bladder, primarily urge incontinence (UI), and to estimate the prevalence of urinary incontinence in the study population. Patient-level data regarding specific drugs used to treat UI and the use of diapers or pads over a 9-month period from October 1995 to May 1996 were retrospectively extracted from the medication databases of 9 Department of Veterans Affairs medical centers. A total of 2233 male patients were included in the analyses. Most patients were receiving oxybutynin chloride (39.8%), dicyclomine hydrochloride (16.0%), or imipramine hydrochloride (13.9%), and the remaining 30.3% were using flavoxate hydrochloride, propantheline bromide, hyoscyamine sulfate, and adult diapers or pads. Overall, 72.1% of patients had been prescribed daily dosages within the recommended dosing ranges for these medications. The majority (91.3%) of patients had not switched to another UI medication during the study period. Based on a chronic disease index, 47.6% of patients had 2 or fewer chronic diseases. Using pooled prevalence estimates, the estimated percentage of patients who had ever experienced UI in this population ranged from 7.4% to 20.8%; however, a considerably smaller percentage were taking medications for the treatment of UI. The results of this study suggest that oxybutynin, dicyclomine, and imipramine are the agents most commonly used to treat urinary incontinence within Veterans Affairs medical centers. The majority of patients who received a prescription for one of these drugs did not routinely refill the medication over the course of the study. There are many reasons for patients not to refill a prescription (eg, ineffectiveness, side effects, complications, obtaining the drug from another source), but the present study did not address the causes.
尿失禁具有广泛的医学、心理、社会和经济影响。这项描述性研究的目的是检查用于治疗膀胱过度活动症症状(主要是急迫性尿失禁[UI])的各种药物的使用模式和停药率,并估计研究人群中尿失禁的患病率。1995年10月至1996年5月期间9个月内用于治疗UI的特定药物以及尿布或尿垫使用情况的患者层面数据,是从9个退伍军人事务部医疗中心的药物数据库中回顾性提取的。共有2233名男性患者纳入分析。大多数患者接受氯奥昔布宁(39.8%)、盐酸双环胺(16.0%)或盐酸丙咪嗪(13.9%)治疗,其余30.3%使用盐酸黄酮哌酯、溴丙胺太林、硫酸莨菪碱以及成人尿布或尿垫。总体而言,72.1%的患者所服用药物的每日剂量在推荐剂量范围内。在研究期间,大多数患者(91.3%)未更换为另一种治疗UI的药物。根据慢性病指数,47.6%的患者患有两种或更少的慢性病。使用汇总患病率估计值,该人群中曾经历过UI的患者估计百分比在7.4%至20.8%之间;然而,正在服用治疗UI药物的患者比例要小得多。这项研究的结果表明,奥昔布宁、双环胺和丙咪嗪是退伍军人事务部医疗中心最常用于治疗尿失禁的药物。接受这些药物之一处方的大多数患者在研究过程中未常规重新配药。患者不重新配药有许多原因(例如,无效、副作用、并发症、从其他来源获取药物),但本研究未探讨原因。